相似文献
1
Use of normal tissue complication probability models in the clinic.
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S10-9. doi: 10.1016/j.ijrobp.2009.07.1754.
2
Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues.
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S3-9. doi: 10.1016/j.ijrobp.2009.09.040.
3
Systematic Review of Normal Tissue Complication Models Relevant to Standard Fractionation Radiation Therapy of the Head and Neck Region Published After the QUANTEC Reports.
Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):391-407. doi: 10.1016/j.ijrobp.2017.09.041. Epub 2017 Sep 29.
4
[Probabilities of controlling tumors and complications (TCP/NTCP) after radiotherapy: methodologic, physical, and biological aspects].
Cancer Radiother. 2002 Nov;6 Suppl 1:155s-165s. doi: 10.1016/s1278-3218(02)00221-4.
5
TCP and NTCP in preclinical and clinical research in Europe.
Rays. 2005 Apr-Jun;30(2):121-6.
6
Normal Tissue Complication Probability (NTCP) modeling of late rectal bleeding following external beam radiotherapy for prostate cancer: A Test of the QUANTEC-recommended NTCP model.
Acta Oncol. 2010 Oct;49(7):1040-4. doi: 10.3109/0284186X.2010.509736.
7
Can dose-response models predict reliable normal tissue complication probabilities in radical radiotherapy of urinary bladder cancer? The impact of alternative radiation tolerance models and parameters.
Int J Radiat Oncol Biol Phys. 2001 Jul 1;50(3):627-37. doi: 10.1016/s0360-3016(01)01464-x.
8
Model-based calculation of thyroid gland normal tissue complication probability in head and neck cancer patients after radiation therapy.
Strahlenther Onkol. 2020 Jun;196(6):561-568. doi: 10.1007/s00066-020-01579-y. Epub 2020 Feb 3.
9
Development of multivariate NTCP models for radiation-induced hypothyroidism: a comparative analysis.
Radiat Oncol. 2012 Dec 27;7:224. doi: 10.1186/1748-717X-7-224.
10
Application of Dempster-Shafer theory in dose response outcome analysis.
Phys Med Biol. 2012 Sep 7;57(17):5575-85. doi: 10.1088/0031-9155/57/17/5575. Epub 2012 Aug 14.
引用本文的文献
1
Dosimetric and Radiobiological Comparison of Three-Dimensional Conformal Radiotherapy and Helical Tomotherapy in Whole Pelvic Radiotherapy of Prostate Cancer Patients.
J Biomed Phys Eng. 2025 Aug 1;15(4):333-340. doi: 10.31661/jbpe.v0i0.2301-1587. eCollection 2025 Aug.
2
The Effects of Radiation Therapy on the Ocular Apparatus: Implications for Management.
Cancers (Basel). 2025 Aug 8;17(16):2605. doi: 10.3390/cancers17162605.
3
Comparison of Quality of Life in Postoperative High-Grade Glioma Patients Treated Using EORTC and RTOG Target Delineation Techniques for Postoperative Radiotherapy.
Asian J Neurosurg. 2025 Apr 21;20(3):506-513. doi: 10.1055/s-0045-1807761. eCollection 2025 Sep.
4
Comprehensive analysis of the role of deep inspiration breath-hold in right-sided breast cancer radiotherapy: A focus on cardiac substructures and right coronary artery.
J Appl Clin Med Phys. 2025 Sep;26(9):e70216. doi: 10.1002/acm2.70216.
5
Diversity and inclusivity in oncology: A narrative review and orientation for institutional measures in Germany.
Transl Oncol. 2025 Oct;60:102493. doi: 10.1016/j.tranon.2025.102493. Epub 2025 Aug 8.
6
Management of critically located brain metastases in patients with precluded survival using customised double-dose prescription-based, adaptive accelerated staged radiosurgery: a long-term retrospective analysis.
Radiat Oncol. 2025 Aug 1;20(1):120. doi: 10.1186/s13014-025-02692-x.
7
Radiotherapy combined with anlotinib in locoregional recurrent esophageal squamous cell carcinoma after radical surgery: a prospective, Phase II clinical trial.
Br J Cancer. 2025 Jul 16. doi: 10.1038/s41416-025-03101-6.
8
Uncertainties in outcome modelling in radiation oncology.
Phys Imaging Radiat Oncol. 2025 May 7;34:100774. doi: 10.1016/j.phro.2025.100774. eCollection 2025 Apr.
9
Stereotactic body radiotherapy for unresectable or locally recurrent pancreatic cancer: A single centre experience.
J Radiosurg SBRT. 2025;9(3):207-213.
10
Radio(chemo)therapy with curative intent for anal cancer - effectiveness and toxicity in elderly vs. younger patients.
Front Oncol. 2025 May 16;15:1567655. doi: 10.3389/fonc.2025.1567655. eCollection 2025.
本文引用的文献
1
The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery.
Semin Radiat Oncol. 2008 Oct;18(4):240-3. doi: 10.1016/j.semradonc.2008.04.005.
2
Value of whole brain re-irradiation for brain metastases--single centre experience.
Clin Oncol (R Coll Radiol). 2007 Sep;19(7):532-8. doi: 10.1016/j.clon.2007.06.001. Epub 2007 Jul 26.
3
Multivariable modeling of radiotherapy outcomes, including dose-volume and clinical factors.
Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1275-86. doi: 10.1016/j.ijrobp.2005.11.022.
4
Orbital lymphoma: is it necessary to treat the entire orbit?
Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):527-30. doi: 10.1016/j.ijrobp.2004.03.039.
5
CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.
Semin Radiat Oncol. 2003 Jul;13(3):176-81. doi: 10.1016/S1053-4296(03)00031-6.
6
Methodological issues in radiation dose-volume outcome analyses: summary of a joint AAPM/NIH workshop.
Med Phys. 2002 Sep;29(9):2109-27. doi: 10.1118/1.1501473.
7
Modeling the effects of inhomogeneous dose distributions in normal tissues.
Semin Radiat Oncol. 2001 Jul;11(3):197-209. doi: 10.1053/srao.2001.23478.
8
Clinical experience with retreatment for palliation.
Semin Radiat Oncol. 2000 Jul;10(3):210-21. doi: 10.1053/s1053-4296(00)80039-9.
9
Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC).
Int J Radiat Oncol Biol Phys. 1999 Sep 1;45(2):323-9. doi: 10.1016/s0360-3016(99)00183-2.
10
A test of the claim that plan rankings are determined by relative complication and tumor-control probabilities.
Int J Radiat Oncol Biol Phys. 1998 May 1;41(2):451-7. doi: 10.1016/s0360-3016(98)00057-1.
Zotero 插件